Carregant...
Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET
Imaging biomarkers can be used to screen participants for Alzheimer's disease clinical trials. To test the predictive values in clinical progression of neuropathology change (amyloid‐PET) or brain metabolism as neurodegeneration biomarker ([18F]FDG‐PET), we evaluated data from N = 268 healthy c...
Guardat en:
| Publicat a: | Ann Clin Transl Neurol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562030/ https://ncbi.nlm.nih.gov/pubmed/31211176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.782 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|